A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies

BACKGROUND: The higher recurrence rate of hepatocellular carcinoma (HCC) needs to be urgently controlled. However, definitive markers are lacking for patients with recurrence of HCC after undergoing minimal invasive therapies—local ablation combined with transcatheter arterial chemoembolization (TAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Ma, Liang, Li, Jianjun, Yuan, Chunwang, Sun, Jianping, Li, Kang, Qin, Ling, Zang, Chaoran, Zhao, Yanan, Zhao, Yan, Zhang, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930388/
https://www.ncbi.nlm.nih.gov/pubmed/31908536
http://dx.doi.org/10.2147/CMAR.S224711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930388/
https://www.ncbi.nlm.nih.gov/pubmed/31908536
http://dx.doi.org/10.2147/CMAR.S224711

Ejemplares similares